Minimal Residual Disease (MRD) by Flow Cytometry
Also known as MRD by Flow Cytometry, Minimal Residual Disease Flow, Flow MRD Test, Leukemia MRD Flow, Immunophenotypic MRD, Post-Treatment Leukemia Assessment, Flow Cytometry MRD
-
Home Collection, Lab Visit
- Reports within3 Working Days
Minimal Residual Disease (MRD) by Flow Cytometry Test in Palakkad Overview
What is the Minimal Residual Disease (MRD) by Flow Cytometry test?
The Minimal Residual Disease (MRD) by Flow Cytometry test is used to detect small numbers of remaining cancer cells in blood or bone marrow after leukemia or lymphoma treatment. The test uses flow cytometry technology to identify abnormal cells with high sensitivity.
Why is the Minimal Residual Disease (MRD) by Flow Cytometry test done?
- To evaluate treatment response in leukemia and lymphoma patients.
- To detect residual cancer cells after therapy.
- To assess the risk of disease relapse.
- To monitor remission status.
- To support long-term cancer management.
Who should get tested for the Minimal Residual Disease (MRD) by Flow Cytometry test?
- Patients undergoing treatment for leukemia or lymphoma.
- Individuals in remission requiring disease monitoring.
- Patients with suspected residual blood cancer cells.
- Individuals advised by haematologists for MRD evaluation.
More about the Minimal Residual Disease (MRD) by Flow Cytometry test
MRD testing is an important part of modern cancer care because even a very small number of residual cancer cells can increase the risk of relapse. The test is commonly performed using blood or bone marrow samples.
Other/Similar names of the test
- MRD Flow Cytometry Test
- Residual Leukemia Cell Detection
- Leukemia Remission Monitoring Test
- Flow Cytometry MRD Analysis
- Measurable Residual Disease
No preparations needed
Minimal Residual Disease (MRD) by Flow Cytometry parameters Includes: 2
Minimal Residual Disease (MRD) by Flow Cytometry
₹13500
WhatsApp to book test
+91 93334-93334
